ResMed Profile

USD 1.11  1.04%

Bona fide gift to Peter Farrell of 10000 shares of ResMed subject to Section 16

ResMed insider trading alert for gift of resmed common stock by Peter Farrell, Executive Chairman, on June 20, 2018. This event was filed by Resmed Inc with SEC on 2009-12-09. Statement of changes in beneficial ownership - SEC Form 4. Peter Farrell is currently serves as non-executive chairman of the board of ResMed [view details]   

ResMed Summary

ResMed (RMD) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 6,000 people. ResMed is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 15.28 B. ResMed runs under Healthcare sector within Medical Equipment industry. This company has 142.74 M outstanding shares of which 0 shares are at this time shorted by investors with about 0.0 days to cover shorted positions. RESMED INC has about 858.9 M in cash with 174.38 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.01.
Check ResMed Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 108.14HorizonTargetOdds Above 108.14
94.45%30 days 108.14 5.39%
Based on normal probability distribution, the odds of ResMed to move above current price in 30 days from now is about 5.39% (This ResMed probability density function shows the probability of ResMed Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares14.5 M1.4 B
Capital World InvestorsCommon Shares11.7 M1.1 B
View ResMed Diagnostics

Selected ResMed Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

ResMed Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for ResMed are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on New York Stock Exchange. It employs 6000 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
CEO and DirectorMichael FarrellView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Medical Equipment
InstrumentUSA Stock View All
RegionNorth America
Business Address9001 Spectrum Center Boulevard
Foreign Associate  Australia
ExchangeNew York Stock Exchange
CIK Number00943819.0
IndustryMedical Equipment
Contact Number858 836 5000
CurrencyUSD - US Dollar


ResMed Analyst Recommendations
Target PriceAdvice# of Analysts
ResMed current and past analyst recommendations published by number of research institutions as well as average analyst consensus
ResMed Analyst Advice  


ResMed Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.7April 25, 2017
ResMed normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


ResMed Corporate Directors
John Wareham Independent Director, MBA
Ronald Taylor Lead Independent Director
Christopher Roberts Independent Director, MBA
Additionally take a look at Your Equity Center. Please also try Cryptocurrency Correlation module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges.